Tag Archives: GMiA

Self-regulation or government regulation of transparency?

In 2012, when edition 17 of Medicines Australia Code was released, the Australian Competition and Consumer Commission (ACCC) limited its authorisation to 2 years, rather than the 5 years sought, to encourage Medicines Australia to improve transparency around payments to … Continue reading

Posted in Pharmaceutical Promotion | Tagged , , | 1 Comment

GSK cops $3 bn fine for largest health care fraud in US; 17th Edition of Medicines Australia Code released

Not surprisingly, these two news items led to a discussion on Australian television (and elsewhere) of whether the promotional activities of the pharmaceutical industry should be governed by self-regulatory industry codes of conduct or by co-regulation involving the government and … Continue reading

Posted in Pharmaceutical Promotion | Tagged , , , , , , , | Leave a comment